Table 1.
Demographics of enrolled subjects who received at least one treatment.
STARS 1 | STARS 2 | |||||||
---|---|---|---|---|---|---|---|---|
Characteristic | Total (n = 60) | HF-LED-RL (n = 36) | Mock (n = 24) | P-value | Total (n = 54)† | HF-LED-RL (n = 33) | Mock (n = 21) | P-value |
Age, years | 55.1 ± 13.0 | 54.7 ± 11.5 | 55.6 ± 15.2 | 0.63 | 56.2 ± 15.5 | 55.0 ± 16.0 | 58.0 ± 14.7 | 0.53 |
Sex | ||||||||
Male | 44 (73.3%) | 26 (72.2%) | 18 (75.0%) | 1.00 | 40 (74.0%) | 23 (69.7%) | 17 (81.0%) | 0.53 |
Female | 16 (26.7%) | 10 (27.8%) | 6 (25.0%) | 14 (26.0%) | 10 (30.3%) | 4 (19.0%) | ||
Race and ethnicity | ||||||||
Caucasian, Not Hispanic or Latino | 36 (60.0%) | 19 (52.8%) | 17 (70.8%) | 0.75 | 54 (100%) | 33 (100%) | 21 (100%) | N/A |
Caucasian, Hispanic or Latino | 4 (6.7%) | 3 (8.3%) | 1 (4.2%) | -- | -- | -- | ||
Black or African American | 16 (26.7%) | 11 (30.6%) | 5 (20.8%) | -- | -- | -- | ||
Asian | 3 (5.0%) | 2 (5.6%) | 1 (4.2%) | -- | -- | -- | ||
Native Hawaiian or Other Pacific Islander | 1 (1.7%) | 1 (2.8%) | 0 (0.0%) | -- | -- | -- |
Age is presented as mean ± SD. Categorical variables are presented as n (%). P-values were calculated by two-sided Wilcoxon ranked sum test for age and Fisher’s exact test for categorical variables. P-values ≤ 0.05 were considered statistically significant.
HF-LED-RL: high fluence light-emitting diode-red light
A total of 55 subjects were enrolled in STARS 2, but 1 subject did not receive the assigned treatment since the intervention was halted per the study protocol.